Evidence map›Paper›PMID 37929590›Full record

ArticleCirculation. Cardiovascular quality and outcomes2024

Percutaneous Coronary Intervention for Heart Failure: Worth the Cost?

Saket Girotra, Dharam J Kumbhani

Open access · bronzeAbstract readEditorialComment
In one paragraph

Article in Circulation. Cardiovascular quality and outcomes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 70% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Saket GirotraDepartment of Medicine, Division of Cardiology, University of Texas-Southwestern Medical Center, Dallas.ORCID 0000-0002-4784-4513
Dharam J KumbhaniDepartment of Medicine, Division of Cardiology, University of Texas-Southwestern Medical Center, Dallas.ORCID 0000-0003-4321-4538
The University of Texas Southwestern Medical Center · US

Funding

Reducing Ethnic-racial Disparities in Cardiac Arrest Survival Outcomes (RED-CASO)R01HL160734 · NHLBI · SAINT LUKE'S HOSPITAL · PI CHAN, PAUL SHEUNG-YAN, GIROTRA, SAKET · 2022 to 2025
$2.6M
Peripheral Artery Disease: Long-term Survival & Outcomes Study (PEARLS)R01HL166305 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI Saket Girotra · 2023 to 2026
$2.5M
Peripheral Artery Disease: Long-term Survival & Outcomes Study (PEARLS)R56HL158803 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI GIROTRA, SAKET · 2021 to 2021
$633k
NHLBI NIH HHS R01 HL160734NHLBI NIH HHS R01 HL166305NHLBI NIH HHS R56 HL158803
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Coronary Artery DiseaseHeart FailurePercutaneous Coronary InterventionCoronary Artery BypassHumansTreatment Outcomecoronary artery bypass graft surgeryheart failuremyocardial revascularizationpercutaneous coronary intervention

Identifiers

PMID37929590
PMCPMC10872480
OpenAlexW4388414332

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.